Salts spacer allows morpholine to protrude out of the

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: 5nib (Iressa) Kinase inhibitors based on ATP Gefi5nib (Iressa): isostere of adenosine halogena5on prevents metabolism by CYP morpholine helps to solubilize the compound Gefi4nib (Iressa) Lead compound Secondary amine HN 4 N CH3 6 Small lipophilic group OMe Electron-donating substituents N 7 OMe I; IC50 5 nM Notes • The secondary amine, electron- dona4ng subs4tuents and small lipophilic group are all important for ac4vity • Useful in vitro ac4vity • Lower in vivo ac4vity due to rapid metabolism • Metabolised by cytochrome P450 enzymes Gefi4nib (Iressa) Metabolism of the lead compound OH HN 4 N N CH3 6 OMe 7 OMe I; IC50 5 nM Cytochrome P450 enzymes Oxida4on HN OH OMe N HN + OMe N N II OMe CH3 N OMe III Notes • Methyl group and para- posi4on of aroma4c ring are suscep4ble posi4ons • Blocking metabolism should improve the half life of the drug Gefi4nib (Iressa) Drug design F HN 4 N CH3 6 HN OMe OMe N N 7 I; IC50 5 nM OMe Cl N OMe IV: IC50 9 nM Notes • Fluoro- subs4tuent blocks para- hydroxyla4on of the aroma4c ring • Fluorine is similar in size to hydrogen and ha...
View Full Document

This note was uploaded on 01/15/2014 for the course CHEM 167 taught by Professor Amaro during the Winter '13 term at UCSD.

Ask a homework question - tutors are online